# DAYVIGO
> **NDA212028** · New Drug Application · Sponsor: EISAI INC · Approved 2019-12-20
## Drug
- **FDA Application Number:** NDA212028
- **Application type:** New Drug Application
- **Brand name:** DAYVIGO
- **Generic name:** LEMBOREXANT
- **Active ingredients:** LEMBOREXANT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EISAI INC
- **Manufacturer:** Eisai Inc.
- **First approval:** 2019-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212028)
---
*AI Analytics · CC0 1.0*